First dual-protection intravaginal ring design shows promise in long-term HIV and pregnancy prevention
A new intravaginal ring (IVR) has been developed for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive. Tenofovir is the ...
Nov 12, 2013
not rated yet | 1